Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Immunology/Infectious Diseases | Dermatology/Plastic Surgery
Hereditary Angioedema
This study is being conducted to evaluate the efficacy of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE).
This study is being conducted to evaluate the efficacy of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE).
This study is being conducted to evaluate the efficacy of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE).
This study is being conducted to evaluate the efficacy of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE).
This study is being conducted to evaluate the efficacy of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE).
This study is being conducted to evaluate the efficacy of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE).
This study is being conducted to evaluate the efficacy of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE).
The purpose of this study is to determine the safety of an experimental drug, when used to try to treat angioedema attacks.
Volunteers needed for acute Hereditary Angioedema Attack research studies.
This study is being conducted to evaluate the efficacy of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE).
This study is being conducted to evaluate the efficacy of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE).
This study is being conducted to evaluate the efficacy of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE).
This study is being conducted to evaluate the efficacy of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE).
Human C1 Esterase Inhibitor (C1-INH) in Subjects with congenital C1-INH Deficiency and Acute Abdominal or Facial HAE Attacks.
This study is being conducted to evaluate the efficacy of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE).
